Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia

被引:180
|
作者
Fervaha, G. [1 ,2 ]
Foussias, G. [1 ,2 ,3 ]
Agid, O. [1 ,2 ,3 ]
Remington, G. [1 ,2 ,3 ]
机构
[1] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
schizophrenia; functional outcome; negative symptoms; neurocognition; amotivation; avolition-apathy; QUALITY-OF-LIFE; CLINICAL ANTIPSYCHOTIC TRIALS; CONSENSUS COGNITIVE BATTERY; EFFECTIVENESS CATIE PROJECT; RANDOMIZED CONTROLLED-TRIAL; NEGATIVE SYMPTOMS; INTRINSIC MOTIVATION; RATING-SCALE; FOLLOW-UP; APATHY;
D O I
10.1111/acps.12289
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
ObjectiveFunctional impairment is characteristic of most individuals with schizophrenia; however, the key variables that undermine community functioning are not well understood. This study evaluated the association between selected clinical variables and one-year longitudinal functional outcomes in patients with schizophrenia. MethodThe sample included 754 patients with schizophrenia who completed both baseline and one-year follow-up visits in the CATIE study. Patients were evaluated with a comprehensive battery of assessments capturing symptom severity and cognitive performance among other variables. The primary outcome variable was functional status one-year postbaseline measured using the Heinrichs-Carpenter Quality of Life Scale. ResultsFactor analysis of negative symptom items revealed two factors reflecting diminished expression and amotivation. Multivariate regression modeling revealed several significant independent predictors of longitudinal functioning scores. The strongest predictors were baseline amotivation and neurocognition. Both amotivation and neurocognition also had independent predictive value for each of the domains of functioning assessed (e.g., vocational). ConclusionBoth motivational and neurocognitive deficits independently contribute to longitudinal functional outcomes assessed 1year later among patients with schizophrenia. Both of these domains of psychopathology impede functional recovery; hence, it follows that treatments ameliorating each of these symptoms should promote community functioning among individuals with schizophrenia.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 50 条
  • [41] Patterns of neurocognitive deficits and unawareness of illness in schizophrenia
    Lysaker, PH
    Lancaster, RS
    Davis, LW
    Clements, CA
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2003, 191 (01) : 38 - 44
  • [42] Baseline neurocognitive deficits in the CATIE schizophrenia trial
    Keefe, Richard S. E.
    Bilder, Robert M.
    Harvey, Philip D.
    Davis, Sonia M.
    Palmer, Barton W.
    Gold, James M.
    Meltzer, Herbert Y.
    Green, Michael F.
    Miller, Del D.
    Canive, Jose M.
    Adler, Lawrence W.
    Manschreck, Theo C.
    Swartz, Marvin
    Rosenheck, Robert
    Perkins, Diana O.
    Walker, Trina M.
    Stroup, T. Scott
    McEvoy, Joseph P.
    Lieberman, Jeffrey A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) : 2033 - 2046
  • [43] Stability and variability in profiles of neurocognitive deficits in schizophrenia
    Tseng, Huai-Hsuan
    Liu, Shi-Kai
    Hsieh, Ming H.
    Hwang, Tzung-Jeng
    Liu, Chih-Min
    Hua, Mau-Sun
    Hwu, Hai-Gwo
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 122S - 123S
  • [44] Motivational Deficits and Cognitive Test Performance in Schizophrenia
    Fervaha, Gagan
    Zakzanis, Konstantine K.
    Foussias, George
    Graff-Guerrero, Ariel
    Agid, Ofer
    Remington, Gary
    [J]. JAMA PSYCHIATRY, 2014, 71 (09) : 1058 - 1065
  • [45] A longitudinal naturalistic study of cognition and functional outcome in schizophrenia: Do specific neurocognitive dimensions are linked with specific domains of community function?
    Bralet, M.
    Magniez, A.
    Neveu, X.
    Eskenazi, A. M.
    Thuy, T. Ton Nu
    Bosset, J.
    Falissard, B.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 583 - 584
  • [46] Social cognition, functional capacity and symptoms in the longitudinal prediction of outcome in subjects with first-episode schizophrenia
    Nordentoft, M.
    Wills, R.
    Gotfredsen, D.
    [J]. EUROPEAN PSYCHIATRY, 2016, 33 : S67 - S67
  • [47] Effectiveness of Integrated Neurocognitive Therapy on Cognitive Impairment and Functional Outcome for Schizophrenia Outpatients
    De Mare, Andreana
    Cantarella, Miriam
    Galeoto, Giovanni
    [J]. SCHIZOPHRENIA RESEARCH AND TREATMENT, 2018, 2018
  • [48] Neurocognitive Impairment in Remitted First Episode Schizophrenia and its Correlation with Functional Outcome
    Sharma, Krishan Kuamr
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S65 - S65
  • [49] The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia
    Heslegrave, RJ
    Awad, AG
    Voruganti, LNP
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1997, 22 (04): : 235 - 243
  • [50] Coping style in schizophrenia: Associations with neurocognitive deficits and personality
    Lysaker, PH
    Bryson, GJ
    Marks, K
    Greig, TC
    Bell, MD
    [J]. SCHIZOPHRENIA BULLETIN, 2004, 30 (01) : 113 - 121